2021 European Heart Rhythm Association Practical Guide on the Use of Non-Vitamin K Antagonist Oral Anticoagulants in Patients with Atrial Fibrillation. Translation of the document prepared by the Czech Society of Cardiology

被引：1

作者：

Taborsky, Milos ^{[1
,2
]}

Kautzner, Josef ^{[3
]}

Fedorco, Marian ^{[1
,2
]}

Curila, Karol ^{[4
,5
]}

Wunschova, Hanka

Pyszko, Jan ^{[1
,2
]}

Novak, Miroslav ^{[6
,7
]}

Kozak, Milan ^{[8
,9
]}

Valek, Martin ^{[10
,11
]}

Polasek, Rostislav ^{[12
]}

Keprt, Patrik

Kubickova, Milena ^{[13
,14
,15
]}

Plasek, Jiri ^{[16
,17
]}

Gloger, Vit ^{[18
]}

Bulava, Alan ^{[19
,20
]}

Vancura, Vlastimil ^{[21
,22
]}

Skala, Tomas ^{[1
,2
]}

Parizek, Petr ^{[23
,24
]}

Danek, Josef ^{[25
,26
]}

机构：

[1] Univ Palackeho Olomouci, Lekarska Fak, Interni Klin Kardiol 1, IP Pavlova 6, Olomouc 77900, Czech Republic

[2] Fak Nemocnice Olomouc, IP Pavlova 6, Olomouc 77900, Czech Republic

[3] Inst Klin Expt Med, Klin Kardiol, Prague, Czech Republic

[4] Univ Karlovy, Lekarska Fak 3, Kardiol Klin, Prague, Czech Republic

[5] Fak Nemocnice Kralovske Vinohrady, Prague, Czech Republic

[6] Masarykovy Univ, Lekarska Fak, Interni Kardioangiol Klin 1, Brno, Czech Republic

[7] Fak Nemocnice Sv Anny Brne, Brno, Czech Republic

[8] Masarykovy Univ, Lekarska Fak, Interni Kardiol Klin, Brno, Czech Republic

[9] Fak Nemocnice Brno, Brno, Czech Republic

[10] Univ Karlovy, Lekarska Fak 1, Interni Klin Kardiol & Angiol, Prague, Czech Republic

[11] Vseobecna Fak Nemocnice Praze, Prague, Czech Republic

[12] Krajska Nemocnice Liberec As, Kardiovask Ctr, Liberec, Czech Republic

[13] Univ JE Purkyne Usti Nad Labem, Fak Zdravotnickych, Kardiol Klin, Usti Nad Labem, Czech Republic

[14] Krajska Zdravotni As, Usti Nad Labem, Czech Republic

[15] Masarykova Nemocnice Usti Nad Labem, Oz, Usti Nad Labem, Czech Republic

[16] Ostravske Univ, Lekarska Fak, Interni Kardiol Klin, Ostrava, Czech Republic

[17] Fak Nemocnice Ostrava, Ostrava, Czech Republic

[18] Krajska Nemocnice Tomase Bati Zline, Kardiol Oddeleni, Zlin, Czech Republic

[19] Nemocnice Ceske Budejovice As, Kardiol Oddeleni, Ceske Budejovice, Czech Republic

[20] Jihoceske Univ Ceskych Budejovicich, Zdravotne Socialni Fak, Ceske Budejovice, Czech Republic

[21] Univ Karlova, Lekarska Fak Plzen, Kardiol Klin, Plzen, Czech Republic

[22] Fak Nemocnice Plzen, Plzen, Czech Republic

[23] Univ Karlovy, Lekarska Fak, Interni Kardioangiol Klin 1, L, Hradec Kralove, Czech Republic

[24] Fak Nemocnice Hradec Kralove, Hradec Kralove, Czech Republic

[25] Univ Karlovy, Lekarska Fak 1, Interni Klin, Kardiol Oddeleni, Prague, Czech Republic

[26] Ustredni Vojenska Nemocnice, Prague, Czech Republic

来源：

COR ET VASA | 2023年 / 65卷

关键词：

apixaban; dabigatran; DOACs; edoxaban; NOACs; rivaroxaban;

D O I：

10.33678/cor.2023.024

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：23 / 75

页数：53

共 50 条

[21] Effectiveness and Safety of Non-Vitamin K Antagonist Oral Anticoagulants in Asian Patients With Atrial Fibrillation
Cha, Myung-Jin
Choi, Eue-Keun
Han, Kyung-Do
Lee, So-Ryoung
Lim, Woo-Hyun
Oh, Seil
Lip, Gregory Y. H.
STROKE, 2017, 48 (11) : 3040 - +
[22] The role of non-vitamin K antagonist oral anticoagulants in Asian patients with atrial fibrillation A PRISMA-compliant article
Liu, Xuyang
Huang, Manxiang
Ye, Caisheng
Zeng, Junquan
Zeng, Changai
Ma, Jianyong
MEDICINE, 2020, 99 (27)
[23] Special considerations for therapeutic choice of non-vitamin K antagonist oral anticoagulants for Japanese patients with nonvalvular atrial fibrillation
Okumura, Ken
Hori, Masatsugu
Tanahashi, Norio
Camm, A. John
CLINICAL CARDIOLOGY, 2017, 40 (02) : 126 - 131
[24] The non-vitamin K antagonist oral anticoagulants in atrial fibrillation patients with high-normal renal function-A systematic review
Huqi, Alda
Zoccali, Carmine
Giugliano, Robert P.
De Caterina, Raffaele
VASCULAR PHARMACOLOGY, 2022, 147
[25] Factors driving the use of warfarin and non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation
Hu, Mu-Mei
Wang, Jui
Chien, Kuo-Liong
Su, Chin-Ling
Lin, Shin-Yi
Wu, Fe-Lin Lin
Lin, Zhen-Fang
JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, 2017, 116 (04) : 276 - 286
[26] Oral Anticoagulation in Japanese Patients With Atrial Fibrillation - Insight to the Use of Non-Vitamin K Antagonist Oral Anticoagulants
Gomez-Molina, Miriam
Valdes, Mariano
Marin, Francisco
CIRCULATION JOURNAL, 2015, 79 (02) : 292 - 294
[27] Ischaemic and haemorrhagic stroke associated with non-vitamin K antagonist oral anticoagulants and warfarin use in patients with atrial fibrillation: a nationwide cohort study
Staerk, Laila
Fosbol, Emil Loldrup
Lip, Gregory Y. H.
Lamberts, Morten
Bonde, Anders Nissen
Torp-Pedersen, Christian
Ozenne, Brice
Gerds, Thomas Alexander
Gislason, Gunnar Hilmar
Olesen, Jonas Bjerring
EUROPEAN HEART JOURNAL, 2017, 38 (12) : 907 - 915
[28] Non-Vitamin K Antagonist Oral Anticoagulants for Stroke Prevention in Asian Patients With Nonvalvular Atrial Fibrillation Meta-Analysis
Wang, Kang-Ling
Lip, Gregory Y. H.
Lin, Shing-Jong
Chiang, Chern-En
STROKE, 2015, 46 (09) : 2555 - 2561
[29] The Impact of Polypharmacy on the Effectiveness and Safety of Non-vitamin K Antagonist Oral Anticoagulants in Patients with Atrial Fibrillation
Grymonprez, Maxim
Petrovic, Mirko
De Backer, Tine L.
Steurbaut, Stephane
Lahousse, Lies
THROMBOSIS AND HAEMOSTASIS, 2024, 124 (02) : 135 - 148
[30] Gaps in translation from trials to practice: Non-vitamin K antagonist oral anticoagulants (NOACs) for stroke prevention in atrial fibrillation
Hylek, Elaine M.
Ko, Darae
Cove, Christina L.
THROMBOSIS AND HAEMOSTASIS, 2014, 111 (05) : 783 - 788

← 1 2 3 4 5 →